VFS
TEVA icon

VSR Financial Services’s Teva Pharmaceuticals TEVA Stock Holding History

VSR Financial Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-8,543
Closed -$457K – 579
2016
Q1 		$457K Sell
8,543
-3,029
-26% -$178K 0.05% 338
2015
Q4 		$760K Buy
11,572
+82
+0.7% +$5.07K 0.08% 253
2015
Q3 		$649K Buy
11,490
+80
+0.7% +$5.19K 0.07% 266
2015
Q2 		$674K Sell
11,410
-141
-1% -$8.7K 0.07% 286
2015
Q1 		$720K Sell
11,551
-4,368
-27% -$254K 0.08% 282
2014
Q4 		$915K Sell
15,919
-1,391
-8% -$77.5K 0.1% 213
2014
Q3 		$930K Sell
17,310
-444
-3% -$23.5K 0.11% 204
2014
Q2 		$931K Sell
17,754
-1,286
-7% -$65.7K 0.12% 199
2014
Q1 		$1.01M Buy
19,040
+926
+5% +$42.8K 0.14% 182
2013
Q4 		$726K Buy
18,114
+1,736
+11% +$68.4K 0.11% 223
2013
Q3 		$619K Buy
16,378
+1,749
+12% +$68.2K 0.11% 220
2013
Q2 		$573K Buy
+14,629
New +$570K 0.11% 211

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VSR Financial Services's TEVA Position: Q2 2016 in Review

VSR Financial Services sold out of Teva Pharmaceuticals (TEVA) in Q2 2016, closing a stake of 8,543 shares — an estimated $457K sold.

VSR Financial Services first reported a position in TEVA in Q2 2013 and held it in 12 quarters. The position peaked at $1.01M in Q1 2014. 812 funds tracked by Wall St. Rank hold TEVA as of Q2 2016.

  • VSR Financial Services reported no remaining Teva Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • VSR Financial Services sold 8,543 Teva Pharmaceuticals shares in Q2 2016, an estimated $457K.
  • VSR Financial Services first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 12 quarters.
  • VSR Financial Services's Teva Pharmaceuticals position peaked at $1.01M in Q1 2014.
  • 812 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2016.

Based on VSR Financial Services's 13F filing for Q2 2016, filed 11 Aug 2016.